MOROZZI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.382
EU - Europa 4.726
AS - Asia 2.406
SA - Sud America 360
AF - Africa 57
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 14.949
Nazione #
US - Stati Uniti d'America 7.304
RU - Federazione Russa 978
CN - Cina 971
GB - Regno Unito 919
SG - Singapore 819
IE - Irlanda 653
IT - Italia 452
UA - Ucraina 439
SE - Svezia 418
DE - Germania 326
BR - Brasile 319
FR - Francia 234
HK - Hong Kong 190
FI - Finlandia 146
KR - Corea 140
VN - Vietnam 92
IN - India 55
CA - Canada 42
ES - Italia 38
NL - Olanda 33
CI - Costa d'Avorio 26
BE - Belgio 25
BD - Bangladesh 18
AR - Argentina 17
MX - Messico 17
TR - Turchia 17
IQ - Iraq 16
JP - Giappone 16
PL - Polonia 14
CZ - Repubblica Ceca 13
ZA - Sudafrica 13
AT - Austria 10
PK - Pakistan 10
SA - Arabia Saudita 10
IR - Iran 9
AU - Australia 6
EU - Europa 6
AZ - Azerbaigian 5
GR - Grecia 5
MA - Marocco 5
VE - Venezuela 5
CH - Svizzera 4
CO - Colombia 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
DK - Danimarca 3
EG - Egitto 3
ID - Indonesia 3
IL - Israele 3
JM - Giamaica 3
OM - Oman 3
PE - Perù 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
JO - Giordania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MC - Monaco 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.949
Città #
Menlo Park 1.653
Southend 804
Dallas 743
Dublin 640
Fairfield 528
Singapore 491
Ashburn 478
Chandler 400
Jacksonville 350
Santa Clara 312
Moscow 272
Woodbridge 271
Beijing 259
Ann Arbor 231
Wilmington 220
Seattle 215
Hong Kong 186
Cambridge 181
Houston 179
Seoul 123
Princeton 120
Nanjing 118
New York 114
Hefei 111
Siena 96
Los Angeles 69
Munich 64
San Diego 58
The Dalles 58
Boardman 53
Nanchang 48
Helsinki 44
San Mateo 41
Buffalo 37
Dearborn 35
São Paulo 32
Turku 31
Ho Chi Minh City 30
Shenyang 29
Hebei 27
Abidjan 26
Shanghai 26
Brussels 24
Rome 24
Milan 23
Tianjin 22
Toronto 22
Columbus 21
Kunming 21
Málaga 21
San Francisco 21
Venezia 19
Falls Church 18
London 17
Changsha 16
Düsseldorf 16
Guangzhou 16
Jiaxing 16
Jinan 16
Denver 15
Dong Ket 15
Zhengzhou 15
Bengaluru 14
Frankfurt am Main 13
Tokyo 13
Brooklyn 12
Chicago 12
Council Bluffs 12
Lancaster 12
Mestre 12
Ningbo 12
Redondo Beach 12
Warsaw 12
Boston 11
San Jose 11
Brno 10
Hanoi 10
Rio de Janeiro 10
Stockholm 10
Belo Horizonte 9
Montreal 9
Washington 9
Atlanta 8
Chennai 8
Johannesburg 8
Mumbai 8
Norwalk 8
Orem 8
Redwood City 8
Roverbella 8
Vienna 8
Hangzhou 7
Mexico City 7
Phoenix 7
Ankara 6
Baghdad 6
Biên Hòa 6
Changchun 6
Genoa 6
Padova 6
Totale 10.535
Nome #
Livello sierico della COMP (Cartilage Oligomeric Matrix Protein): Uso potenziale come marker di progressione del danno articolare nei pazienti con "Early Rheumatoid Arthritis" 412
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 372
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 364
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 326
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 290
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 279
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis 276
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 271
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 270
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 266
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 263
Antinuclear Human Autoantibodies as Markers in Nicotiana Tabacum Pollen Tubes 242
The Immunogenetics of the Antiphospholipid Syndrome, Anticardiolipin Antibodies, and Lupus Anticoagulant 241
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 241
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study 241
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 239
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 234
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 233
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 229
Anomalie cromosomiche, valutate come frequenza di micronuclei spontanei, in soggetti con fenomeno di Raynaud sospetto presclerodermico [Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon] 229
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 225
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 224
Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis 224
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 223
Chromosome aberrations in Raynaud's phenomenon 222
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 219
Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and systemic sclerosis. 217
Anti-proteinase 3 antibodies in diffuse systemic sclerosis (SSc) with normotensive renal impairment: is it suggestive for an overlapping between SSc and idiopathic vasculitis? 215
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohoert of SLE patients 214
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 211
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies 210
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 208
Comportamento delle purine plasmatiche e urinarie dopo dieta apurinica in soggetti normali e gottosi. 204
Esame del liquido sinoviale 200
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 198
Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis 198
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study 190
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 190
Thiopurine methyltransferase activity in the erythrocytes of adults and children: and HPLC-linked assay 188
Clearance of oxypurines and uric acid in gouty patients [Clearance delle ossipurine e dell'acido urico in soggetti gottosi] 188
Allelic variations of DPB1, DQA1, DQB1 and DRB1 and rheumatoid arthritis: further genetic and statistical considerations [Varianti alleliche dei DPB1, DQA1, DQB1, DRB1 e artite reumatoide: ulteriori considerazioni genetiche e statistiche] 186
Ruolo degli autoanticorpi nella diagnosi della colangite sclerosante primitiva 185
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 184
Serologic profile and mortality rates of scleroderma renal crisis in Italy 183
Modification of DNA patterns in plasma and nucleated blood cells from systemic sclerosis patients 180
Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis 180
Semeiotica di laboratorio delle malattie reumatiche 177
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) 175
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 172
Usefulness of the determination of C reactive protein and other acute phase proteins in rheumatoid arthritis [Utilità del dosaggio della proteina C reattiva e di altre proteine della fase acuta nell'artrite reumatoide] 171
L'elettroforesi bidimensionale su gel di poliacrilamide nello studio dei profili proteici sierici nell'artrite reumatoide 168
Epidemiologic study about hyperuricemia's prevalence on an unselected champion of subjects, in a village of Siena's province 162
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature 162
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 161
Evaluation of the clinical therapeutic response to oral gold salts in patients with rheumatoid arthritis 158
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 157
Immunogenetics of the antiphospholipid syndrome 156
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 155
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 155
Lessons from the "Euro-Lupus Cohort" 154
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 154
Comparison of different methods for the detection ofanti-Ro/SSA antibodies in connective tissue diseases. 149
Human serum recognizes components of plant cells: New research perspectives [Sieri umani riconoscono componenti di cellule vegetali: Nuove prospettive di ricerca] 143
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies 141
HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus : correlation with clinical and autoantibody subsets 140
Is two dimensional polyacrilamide gel electrophoresis a usful technique for the study of serum protein profiles in rheumatoid arthritis 131
Effect of local corticosteroid injection in carpal tunnel syndrome: Clinical and electrophysiological aspects [Efficacia del trattamento con cortisonoci nella sindrome del tunnel carpale idiopatica: studio clinico e neurofisiologico] 121
In vitro study on the possible inflammatory mechanism of ferrous ions: effect on the production of oxygen free radicals [Studi in vitro sul possibile meccanismo flogogeno degli ioni ferro: azione sulla produzione di radicali liberi dell'ossigeno] 118
null 117
Lesch-Nyhan syndrome: Observations on a clinical case [La sindrome di Lesch-Nyhan: osservazione di un caso clinico] 105
Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Revision 2015 103
Immunogenetics of systemic lupus erythematosus: The contribution of DRB3 and DQB1 alleles [Immunogenetica del lupus eritematoso sistemico: il ruolo degli alleli DRB3 e DQB1] 101
PARP activity and NAD concentration in PMC from patients affected by systemic sclerosis and lupus erythematosus 97
The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. 95
null 89
null 69
Il test ANA-reflex.The ANA-reflex test. 55
Antibodies to the lens and cornea in anti-DFS70-positive subjects 6
A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases. 4
Rheumatoid factor isotypes in patients with erosive osteoarthritis of the hand. 3
Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni. 2
Totale 15.010
Categoria #
all - tutte 40.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021724 0 0 0 0 0 149 51 174 127 65 99 59
2021/2022897 59 108 51 108 39 20 41 38 31 102 73 227
2022/20231.406 86 122 203 205 146 270 16 117 145 25 56 15
2023/20241.062 41 22 86 93 41 299 336 24 12 9 11 88
2024/20252.029 35 112 174 102 301 109 44 122 190 79 243 518
2025/20263.365 390 689 556 543 1.030 157 0 0 0 0 0 0
Totale 15.010